SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRotork Regulatory News (ROR)

Share Price Information for Rotork (ROR)

Share Price is delayed by 15 minutes
Get Live Data
305.60    2.00 (0.66%)
Bid:
305.40
Ask:
306.00
Spread: 0.60 (0.196%)
Market Cap: £2.49b
ROR Live PriceLast checked at - London Stock Exchange

Intraday Rotork Share Chart

Director/PDMR Shareholding

9 Mar 2021 15:30

RNS Number : 6894R
Rotork PLC
09 March 2021
 

 

9 March 2021

 

Rotork plc

 ("Company")

 

Notification of transactions by Persons Discharging Managerial Responsibilities ("PDMRs")

 

The Company provides notification of the following transactions, all effected on 8 March 2021 outside of a market venue, relating to the five below named PDMRs and their respective interests in the ordinary share capital of the Company ("Shares") (ISIN: GB00BVFNZH21).

 

The transactions arise from the audited 84.4% vesting and immediate dealing by the PDMRs in their respective three-year performance related nil cost option ("NCO") over, or conditional award ("CA") of, certain Shares granted to them on either the 7 March or the 1 November 2018 under the Company's Long Term Incentive Plan 2010 ("LTIP").

 

The individual PDMR transaction details are set out in the table below:

 

Name and position of PDMR

No. and type of Shares granted on 7 March 2018 (unless otherwise stated)

 

No. of vested Shares acquired on NCO exercise or CA release on 8 March 2021 ¹ ²

No. of acquired Shares sold at 365.20p per Share ³ ⁴

 

No. of acquired Shares retained by PDMR

 

Kevin Hostetler, 

Chief Executive

 

340,393 CA

 

287,291

129,526

157,765 ⁵

Jonathan Davis, Group Finance Director

 

163,461 NCO

137,961

64,615

 

 

73,346 ⁵ ⁶

Grant Wood, Operations Director

 

57,802 NCO

48,784

37,625

11,159 ⁶

 

 

Paul Burke, Chief Information Officer

 

55,824 NCO

47,115

47, 115

 

 

-

Katherine Callaghan, Group Human Resources Director

 

49,366 NCO (1 November 2018)

 

41,664

 

19,293

22,371 ⁶

¹ Full details of the audited 84.4% 2018 LTIP vesting level, in particular as regards the performance outturns for each of the EPS, TSR and ROIC targets set at the time of grant for the three-year financial period ended 31 December 2020, will appear in the Directors' Remuneration Report to the Company's 2020 Annual Report due to be published on 30 March 2021.

² The Shares acquired were all existing market purchased Shares delivered from the Company's Employee Benefit Trust ("EBT").

³ The Shares sold were purchased by the EBT at the MMQ of 365.20p per share for the business day immediately preceding the date of the transaction, ie on 5 March 2021.

The Shares sold by each of Messrs. Hostetler, Davis and Callaghan were sufficient to cover their immediate personal income tax and social security liability arising on acquisition. Messrs. Wood and Burke each sold more Shares than was necessary to meet their personal liability.

5 The net of tax Shares retained by Messrs. Hostetler and Davis as Executive Directors remain subject to the clawback provisions of the LTIP rules. These Shares are also subject to a compulsory two-year holding period commencing from the date of vesting and therefore expiring on 8 March 2023.

The Shares retained are held in the name of the PDMR's spouse, a Person Closely Associated with them as defined under the EU Market Abuse Regulation ("MAR").

 

The Company can confirm that each of the above named PDMRs have complied with their respective obligation to notify the Financial Conduct Authority of the above transactions as required under MAR.

 

- END -

 

Rotork contact and telephone number for enquiries:

Sandra Forbes, Group General Counsel & Company Secretary (Interim)

++44 (0) 7775 703 579

 

Notes:

Legal Entity Identifier: 213800AH5RZIHGWRJ718

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBSGDXSUGDGBC
Date   Source Headline
11th Jun 202612:08 pmRNSDirector/PDMR Shareholding
1st Jun 20269:34 amRNSTotal Voting Rights
18th May 20267:00 amRNSTransaction in Own Shares
14th May 20265:57 pmRNSDirector/PDMR Shareholding
12th May 202612:25 pmRNSDirector/PDMR Shareholding
11th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
1st May 202610:45 amRNSResult of AGM
1st May 20269:53 amRNSTotal Voting Rights
1st May 20267:00 amRNSTrading update
27th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 202610:49 amRNSDirector/PDMR Shareholding
21st Apr 20264:58 pmRNSHolding(s) in Company
20th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20263:18 pmRNSDirector/PDMR Shareholding
15th Apr 20261:19 pmRNSShare buyback programme
13th Apr 20264:37 pmRNSDirector/PDMR Shareholding
13th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20268:52 amRNSDirector/PDMR Shareholding
7th Apr 20269:52 amRNSTransaction in Own Shares - Clarification Notice
7th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20269:10 amRNSTotal Voting Rights
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20263:03 pmRNS2025 Annual Report and Notice of 2026 AGM
26th Mar 20261:55 pmRNSDirector/PDMR Shareholding
25th Mar 202611:36 amRNSDirector/PDMR Shareholding
23rd Mar 20262:38 pmRNSHolding(s) in Company
23rd Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 202611:01 amRNSDirector/PDMR Shareholding
13th Mar 20261:54 pmRNSShare buyback programme
11th Mar 20264:00 pmRNSHolding(s) in Company
11th Mar 20264:00 pmRNSHolding(s) in Company
11th Mar 202612:16 pmRNSDirector/PDMR Shareholding
11th Mar 202612:16 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNS2025 full year results
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20261:16 pmRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.